What is Cloacina?
Cloacina specializes in the manufacturing of stainless steel package wastewater treatment plants and associated equipment. Its product portfolio includes advanced systems such as Membrane Bioreactors, Aerated Sludge Handling Systems, and Primary Treatment Systems. The company serves a diverse clientele across engineering, development, wineries, municipalities, and the food and beverage industries. With four generations of experience, Cloacina is a family-owned and operated business led by licensed wastewater professionals, emphasizing a deep-rooted expertise in the field.
How much funding has Cloacina raised?
Cloacina has raised a total of $762K across 2 funding rounds:
Debt
$350K
Debt
$412K
Debt (2020): $350K with participation from PPP
Debt (2021): $412K led by PPP
Key Investors in Cloacina
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Cloacina?
The recent major strategic investment positions Cloacina for continued development and market penetration. Given the 'enterprise-level funding' context, the company is likely focused on scaling its manufacturing capabilities, expanding its service reach, and potentially integrating new technologies into its treatment plant solutions. This strategic financing will enable Cloacina to further solidify its role as a key provider of wastewater treatment infrastructure, addressing the growing demands of municipalities and industrial clients for efficient and reliable systems. Future growth may involve enhancing product offerings and exploring new market segments.
See full Cloacina company page